3. Hemoglobin copy

Page 1: Anemia Definition

  • Anemia is defined as a deficiency of hemoglobin in the blood.

  • This deficiency can arise from two primary causes:

    • Too few RBCs (red blood cells)

    • Insufficient hemoglobin in the existing red blood cells

Page 2: Blood Loss Anemia

  • Blood Loss Anemia can occur after rapid hemorrhage:

    • The body compensates by replacing the plasma fluid within 1 to 3 days.

    • This quick response leads to a dilution of red blood cells, resulting in low RBC concentration.

    • If no further hemorrhage occurs, RBC concentration typically normalizes within 3 to 6 weeks.

    • Chronic blood loss can lead to:

      • Difficulty absorbing enough iron from the intestines.

      • Production of microcytic hypochromic anemia, characterized by smaller-than-normal RBCs with inadequate hemoglobin.

Page 3: Aplastic Anemia

  • Aplastic Anemia results from bone marrow dysfunction:

    • Condition defined as lack of functioning bone marrow.

    • Causes include:

      • High-dose radiation exposure.

      • Chemotherapy for cancer treatment.

      • Exposure to toxic chemicals (e.g., insecticides, benzene).

      • Autoimmune disorders (like lupus erythematosus) attacking healthy stem cells.

      • Approximately 50% of cases are idiopathic (unknown causes).

    • Treatment options:

      • Blood transfusions to temporarily increase RBC levels.

      • Bone marrow transplantation as a more permanent solution.

Page 4: Megaloblastic Anemia

  • Megaloblastic Anemia develops from the deficiency of vitamin B12, folic acid, and intrinsic factor:

    • This leads to slow erythroblast reproduction in the bone marrow.

    • Resulting RBCs are oversized and misshapen, known as megaloblasts.

    • Conditions causing this include:

      • Atrophy of stomach mucosa (e.g., pernicious anemia).

      • Total gastrectomy (removal of stomach).

Page 5: Impact of Nutrient Absorption

  • Megaloblastic anemia can also arise in patients with intestinal sprue:

    • In this condition, folic acid, vitamin B12, and other vitamin B compounds are poorly absorbed.

    • Erythroblasts cannot proliferate quickly enough, resulting in oversized and fragile RBCs.

    • These fragile cells rupture easily, leading to anemia severity.

Page 6: Hemolytic Anemia

  • Hemolytic Anemia is caused by RBC abnormalities:

    • Results in fragile cells that rupture easily in capillaries, particularly in the spleen.

    • RBC lifespan is shortened, causing serious anemia despite a normal or high RBC count in some diseases.

    • Hereditary Spherocytosis:

      • RBCs are spherical instead of biconcave.

      • They cannot withstand compression, leading to rupture in tight vascular areas.

Page 7: Sickle Cell Anemia

  • Sickle Cell Anemia is characterized by the abnormal hemoglobin type known as hemoglobin S:

    • Affects 0.3% to 1.0% of West African and American blacks.

    • Abnormal beta chains in hemoglobin cause the cells to form elongated crystals when oxygen levels are low.

    • Resulting in the sickle shape of RBCs instead of the normal biconcave disk.

Page 8: Crisis in Sickle Cell Disease

  • The abnormal hemoglobin leads to RBC membrane damage, increasing fragility:

    • This fragility can cause a sickle cell disease crisis, where low oxygen causes sickling leading to RBC rupture.

    • This cycle of sickling and destruction escalates rapidly and can be life-threatening.

Page 9: Erythroblastosis Fetalis

  • Erythroblastosis Fetalis involves Rh-positive RBCs of the fetus being attacked by antibodies from an Rh-negative mother:

    • This causes fragility and rapid rupturing of RBCs.

    • The fetus produces an excess of early blast forms of RBCs to compensate for cell destruction.

Page 10: Secondary Polycythemia

  • Secondary Polycythemia occurs in response to hypoxia:

    • Conditions like high altitude or cardiac failure stimulate an increase in RBC production.

    • Typically, the RBC count can rise to 6 to 7 million/mm3, roughly 30% above normal.

    • Physiological polycythemia is commonly seen in people living at high altitudes (14,000 to 17,000 feet).

Page 11: Polycythemia Vera

  • Polycythemia Vera (or Erythremia) is a pathological condition with an RBC count of 7 to 8 million/mm3 and a hematocrit of 60% to 70%:

    • Caused by a genetic mutation in blood cell production (hemocytoblastic cells).

    • The condition leads to unchecked RBC production despite existing cell levels.

    • Often results in overproduction of white blood cells and platelets.

Page 12: Consequences of Polycythemia Vera

  • In polycythemia vera, both hematocrit and total blood volume increase significantly:

    • Blood volume can nearly double.

    • The vascular system becomes engorged, with many capillaries potentially blocked due to thick blood.

    • Blood viscosity can increase from normal (3 times that of water) to 10 times.

Page 13: Erythropoietin Feedback Mechanism

  • The feedback circuit for erythropoietin responds to oxygen delivery levels:

    • A) For anemia (decreased erythrocyte mass), erythropoietin secretion increases and RBC production rises.

    • B) For hypoxia (lower arterial oxygen saturation), erythropoietin secretion similarly increases, promoting erythrocyte production.

    • C) In polycythemia vera (increased erythrocyte mass), erythropoietin production decreases.